Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Should autologous HSCT be a first-line option in highly active MS: YES.
GABAB receptors in glial cells: from physiological regulation to pathological implications.
The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barré syndrome in Japan.
NEK7 Cys298 is important for NLRP3 inflammasome and targetable by dimethyl fumarate.
The Gut-Lung Axis, Epigenetics and Respiratory Disease.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO.
Clinicoradiologic profile of neuromyelitis optica spectrum disorder in a Kashmiri cohort: a prospective observational cohort study.
Counteracting inactivity deconditioning with graded hypergravity loading: From clinical neurorehabilitation to space medicine.
Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
EBV viral load and miR-BART10-3p expression in multiple sclerosis: A case-control study.
Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities.
Profound Asymptomatic Hyponatremia Associated With Anuric Acute Kidney Injury: Successful Controlled Correction Using Short Intermittent Hemodialysis.
Web of Science Bibliometrics Analysis of Magnetic Resonance Imaging Research Advances in Multiple Sclerosis.
Population and brain diversity are missing from the integrated framework of MS susceptibility.
Risk Factors for Urinary Tract Infections in Patients with Multiple Sclerosis.
Varicella-zoster virus infection triggering GD3 antibody-positive variant Guillain-Barré syndrome: a case report and literature review.
Demyelination in Vascular Dementia: Focus on Oligodendrocytes, Microglia, and Their Interaction.
The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging.
Essential elements for guiding patient segmentation in precision pharmacotherapy for rheumatoid arthritis: lessons up to 2025.
Primary adrenal insufficiency resulting in diagnosis of rare pathogenic variant in X-linked adrenoleukodystrophy.
Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
[Prospects for retroelement-targeted therapy of schizophrenia].
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosis.
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.

Pages